Prelude Capital Management, LLC Medicinova Inc Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.99 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$825,7770.0% of portfolio
-
Citigroup Inc448KShares$806,3220.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $88.3M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...